# A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

> **NCT00721812** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 87 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** GSK1399686

## Key facts

- **NCT ID:** NCT00721812
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-25
- **Primary completion:** 2009-05-27
- **Final completion:** 2009-05-27
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721812, "A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00721812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*